Altered Lymphatic Vessel Anatomy and Markedly Diminished Lymph Clearance in Affected Hands of Patients With Active Rheumatoid Arthritis

Richard D. Bell; Homaira Rahimi; H. Mark Kenney; Alicia A. Lieberman; Ronald W. Wood; Edward M. Schwarz; Christopher T. Ritchlin

doi:10.1002/art.41311

Altered Lymphatic Vessel Anatomy and Markedly Diminished Lymph Clearance in Affected Hands of Patients With Active Rheumatoid Arthritis

Arthritis & Rheumatology ◽

10.1002/art.41311 ◽

2020 ◽

Vol 72 (9) ◽

pp. 1447-1455

Author(s):

Richard D. Bell ◽

Homaira Rahimi ◽

H. Mark Kenney ◽

Alicia A. Lieberman ◽

Ronald W. Wood ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Lymphatic Vessel ◽

Active Rheumatoid Arthritis ◽

Vessel Anatomy

Download Full-text

Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis

Case Medical Research ◽

10.31525/ct1-nct03926195 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Psoriatic Arthritis ◽

Ankylosing Spondylitis ◽

Active Rheumatoid Arthritis ◽

Axial Spondyloarthritis ◽

Semen Parameters ◽

Adult Males

Download Full-text

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Case Medical Research ◽

10.31525/ct1-nct03980483 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Efficacy And Safety

Download Full-text

A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis

Case Medical Research ◽

10.31525/ct1-nct04171414 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Auto Injector

Download Full-text

A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis

Case Medical Research ◽

10.31525/ct1-nct04230213 ◽

2020 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Comparative Study ◽

Active Rheumatoid Arthritis

Download Full-text

Faculty Opinions recommendation of Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1138909.596003 ◽

2008 ◽

Author(s):

Yusuf Yazici

Keyword(s):

Rheumatoid Arthritis ◽

Triple Therapy ◽

Active Rheumatoid Arthritis ◽

Controlled Trial ◽

Treatment Strategies ◽

Single Blind

Download Full-text

Faculty Opinions recommendation of The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1164186.624873 ◽

2009 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Jak Inhibitor ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718325310.793492804 ◽

2014 ◽

Author(s):

Ronald van Vollenhoven

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Tumour Necrosis Factor Alpha ◽

Methotrexate Therapy ◽

Human Antibody ◽

Necrosis Factor Alpha ◽

Subcutaneous Injections ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

THU0199 Week 12 Clinical Response to Certolizumab Pegol Predicts Long-Term Outcomes Regardless of Concomitant Medications and Baseline Disease Characteristics in Japanese Patients with Active Rheumatoid Arthritis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.727 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A231.1-A231

Author(s):

H. Yamanaka ◽

K. Yamamoto ◽

T. Takeuchi ◽

N. Ishiguro ◽

Y. Tanaka ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Response ◽

Active Rheumatoid Arthritis ◽

Certolizumab Pegol ◽

Japanese Patients ◽

Long Term Outcomes ◽

Disease Characteristics ◽

Concomitant Medications

Download Full-text

THU0609 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Background Methotrexate Therapy: Table 1.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.1239 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 412.2-413 ◽

Cited By ~ 1

Author(s):

E. Keystone ◽

P. Taylor ◽

Y. Tanaka ◽

C. Gaich ◽

A.M. DeLozier ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Active Rheumatoid Arthritis ◽

Methotrexate Therapy ◽

Inadequate Response ◽

Phase 3 ◽

Patient Reported

Download Full-text